{
    "clinical_study": {
        "@rank": "38653", 
        "acronym": "FAME 3", 
        "arm_group": [
            {
                "arm_group_label": "FFR guided PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients undergoing PCI will have FFR measured with a St. Jude Medical coronary pressure wire across all lesions.  If the FFR is \u22640.80, then PCI will be performed with the Medtronic Resolute Integrity drug-eluting stent (DES) as per usual routine.  If the FFR is >0.80 then PCI will be deferred. Only those sites with prior experience measuring FFR will be included in the FAME 3 trial.  These patients in whom FFR of a particular lesion was not possible will be included in all analyses based on the intention to treat principle."
            }, 
            {
                "arm_group_label": "CABG", 
                "arm_group_type": "Active Comparator", 
                "description": "CABG will be performed as per clinical routine at each participating center. Both off-pump and on-pump surgery are acceptable, as long as the surgeon and the site are experienced in the particular technique.  An internal mammary graft to the LAD should be attempted in all cases, if feasible.  Complete arterial revascularization is strongly recommended, however, each center should use a conduit strategy with which they are most comfortable.  All vessels \u2265 1,5 mm in diameter and with \u2265 50% stenosis should be bypassed, if technically feasible."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary\n      pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided\n      percutaneous coronary intervention (PCI) in patients with multivessel coronary artery\n      disease (CAD) will result in similar outcomes to coronary artery bypass graft surgery\n      (CABG)."
        }, 
        "brief_title": "A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease", 
        "completion_date": {
            "#text": "June 2021", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Disease", 
            "Coronary Stenosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Coronary Stenosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The FAME 3 trial is a multicenter, international, randomized, controlled noninferiority\n      trial.  All patients with multivessel CAD (not involving the left main) will be screened by\n      the site's Heart Team (including but not limited to an interventional cardiologist, cardiac\n      surgeon and research coordinator).  If all agree that the patient can be treated either with\n      FFR-guided PCI or CABG, and all inclusion criteria are met and no exclusion criteria are\n      met, then the patient will be randomized.\n\n      Baseline clinical, functional, laboratory and electrocardiographic data will be obtained.\n      Patients will receive treatment within 4 weeks of randomization. Patients randomized to CABG\n      will receive state of the art therapy at the discretion of the local surgeon with a strong\n      emphasis on arterial revascularization.  Patients undergoing PCI will have FFR measured with\n      a St. Jude Medical coronary pressure wire across all lesions.  If the FFR is \u22640.80, then PCI\n      will be performed with the Medtronic Resolute Integrity drug-eluting stent (DES) as per\n      usual routine.  If the FFR is >0.80 then PCI will be deferred.\n\n      All patients will receive medical therapy as per published guidelines. Patients will\n      follow-up at 1 and 6 months, and 1 and 3 years with an evaluation of clinical status,\n      functional status, medications and events. Follow-up may be extended to 5 years, if funding\n      allows.\n\n      Core lab analyses will include formal quantitative coronary angiography (QCA) of the\n      baseline angiograms with calculation of the Synergy between Percutaneous Coronary\n      Intervention with Taxus and Cardiac Surgery (SYNTAX) score and Functional SYNTAX Score."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Age \u2265 21 years with angina and/or evidence of myocardial ischemia\n\n          -  2. Three vessel CAD, defined as \u2265 50% diameter stenosis by visual   estimation in\n             each of the three major epicardial vessels or major side branches, but not involving\n             left main coronary artery, and amenable to revascularization by both PCI and CABG as\n             determined by the Heart Team. Patients with a non-dominant right coronary artery may\n             be included if only the left anterior descending artery (LAD) and left circumflex\n             have \u226550% stenosis\n\n          -  3. Willing and able to provide informed, written consent\n\n        Exclusion Criteria:\n\n          -  1. Requirement for other cardiac or non-cardiac surgical procedure (e.g.,  valve\n             replacement, carotid revascularization)\n\n          -  2. Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support\n\n          -  3. Recent STEMI (<5 days prior to randomization)\n\n          -  4. Ongoing Non STEMI with biomarkers (cardiac troponin) still rising\n\n          -  5. Known left ventricular ejection fraction <30%\n\n          -  6. Life expectancy < 2 years\n\n          -  7. Requiring renal replacement therapy\n\n          -  8. Undergoing evaluation for organ transplantation\n\n          -  9. Participation or planned participation in another clinical trial, except for\n             observational registries\n\n          -  10. Pregnancy\n\n          -  11. Inability to take dual antiplatelet therapy for six months\n\n          -  12. Previous CABG\n\n          -  13. Left main disease requiring revascularization\n\n          -  14. Extremely calcified or tortuous vessels precluding FFR measurement\n\n          -  15. Any target lesion with in-stent drug-eluting stent restenosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "1500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02100722", 
            "org_study_id": "FAME 3"
        }, 
        "intervention": [
            {
                "arm_group_label": "FFR guided PCI", 
                "intervention_name": "FFR guided PCI", 
                "intervention_type": "Procedure", 
                "other_name": "Fractional Flow Reserve-Guided PCI"
            }, 
            {
                "arm_group_label": "CABG", 
                "intervention_name": "CABG", 
                "intervention_type": "Procedure", 
                "other_name": "Coronary Artery Bypass Graft Surgery"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 7, 2014", 
        "location": [
            {
                "contact": {
                    "email": "wfearon@stanford.edu", 
                    "last_name": "William F Fearon, MD", 
                    "phone": "650-725-2621"
                }, 
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94305-2004"
                    }, 
                    "name": "Stanford University"
                }, 
                "investigator": {
                    "last_name": "William F Fearon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "Atlanta VA Medical Center"
                }
            }, 
            {
                "contact": {
                    "email": "dgriza@uic.edu"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Jesse Brown VA Medical Center"
                }, 
                "investigator": {
                    "last_name": "Mladen Vidovich, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cwhited@northeastcardiology.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Bangor", 
                        "country": "United States", 
                        "state": "Maine"
                    }, 
                    "name": "Northeast Cardiology Associates"
                }, 
                "investigator": {
                    "last_name": "Peter Ver Lee, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "University of North Carolina"
                }
            }, 
            {
                "contact": {
                    "email": "susanne.donovan@uphs.upenn.edu"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "Penn Presbyterian Medical Center"
                }, 
                "investigator": {
                    "last_name": "William H Matthai, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "michael.jessen@utsouthwestern.edu"
                }, 
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "VA North Texas Health Care System"
                }, 
                "investigator": {
                    "last_name": "Emmanouil Brilakis, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "guspichard@gmail.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Washington Hospital Center"
                }, 
                "investigator": {
                    "last_name": "Augusto Pichard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "bernard.de.Bruyne@OLVZ-aalst.be", 
                    "last_name": "Bernard de Bruyne, MD, PhD", 
                    "phone": "003253 72 44 47"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium", 
                        "zip": "9300 Aalst"
                    }, 
                    "name": "Cardiovascular Center Aalst"
                }, 
                "investigator": {
                    "last_name": "Bernard de Bruyne, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "caroline.vallieres.chum@ssss.gouv.qc.ca"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada"
                    }, 
                    "name": "Le'Centre Hospitalier de l'Universite de Montreal"
                }, 
                "investigator": {
                    "last_name": "Samer Mansour, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "philippe.l_lallier@icloud.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada"
                    }, 
                    "name": "Montreal Heart Institute"
                }, 
                "investigator": {
                    "last_name": "Philippe L'Allier, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jana.rutarova@cktch.cz"
                }, 
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Masaryk University and University Hospital Brno"
                }, 
                "investigator": {
                    "last_name": "Petr Kala, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Liz.coling@homolka.cz"
                }, 
                "facility": {
                    "address": {
                        "city": "Praha", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Na Homolce Hospital"
                }, 
                "investigator": {
                    "last_name": "Martin Mates, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Thomas.engstroem@rh.regionh.dk", 
                    "last_name": "Thomas Engstroem, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark"
                    }, 
                    "name": "Rigshospitalet University Hospital"
                }, 
                "investigator": {
                    "last_name": "Thomas Engstroem, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "janine.salandre@chu-lyon.fr"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "Cardiovascular Hospital"
                }, 
                "investigator": {
                    "last_name": "Gilles Rioufol, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Toth.gabr@gmail.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary"
                    }, 
                    "name": "Hungarian Institute of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Zsolt Piroth, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sjpark@summitmd.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "investigator": {
                    "last_name": "Seung-Jung Park, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jurgina.vaitkiene@santa.lt"
                }, 
                "facility": {
                    "address": {
                        "city": "Vilnius", 
                        "country": "Lithuania"
                    }, 
                    "name": "Vilnius University Hospital Santariskiu Klinikos"
                }, 
                "investigator": {
                    "last_name": "Giedrius Davidavicius, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Nico.Pijls@inter.nl.net", 
                    "last_name": "Nico HJ Pijls, MD, PhD", 
                    "phone": "040-2398360"
                }, 
                "contact_backup": {
                    "email": "frederik.zimmermann@cze.nl", 
                    "last_name": "Frederik M Zimmermann, MD", 
                    "phone": "040-2398360"
                }, 
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5623 EJ"
                    }, 
                    "name": "Catharina Hospital Eindhoven"
                }, 
                "investigator": [
                    {
                        "last_name": "Nico HJ Pijls, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Frederik M Zimmermann, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "iatros007@gmail.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia"
                    }, 
                    "name": "University Clinical Center of Serbia"
                }, 
                "investigator": {
                    "last_name": "Branko Beleslin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kragujevac", 
                        "country": "Serbia"
                    }, 
                    "name": "Clinical Center Kragujevac"
                }
            }, 
            {
                "contact": {
                    "email": "malin.an.persson@sodersjukhuset.se"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Karolinska Institutet, Dep of clinical science and education, S\u00f6dersjukhuset"
                }, 
                "investigator": {
                    "last_name": "Nils Witt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hedvig.tjerneld@ds.se"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Danderyds Sjukhus"
                }, 
                "investigator": {
                    "last_name": "Nikolaos \u00d6stlund Papadogeorgos, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "gmanoharan@msn.com"
                }, 
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Royal Victoria Hospital"
                }, 
                "investigator": {
                    "last_name": "Ganesh Manoharan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Joanne.kelly@gjnh.scot.nhs.uk"
                }, 
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Golden Jubilee National Hospital"
                }, 
                "investigator": {
                    "last_name": "Keith G Oldroyd, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "joanne.jessup@nhs.net"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Kings College Hospital"
                }, 
                "investigator": {
                    "last_name": "Philip MacCarthy, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Jaydeep.Sarma@UHSM.NHS.UK"
                }, 
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Wythenshawe Hospital"
                }, 
                "investigator": {
                    "last_name": "Jaydeep Sarma, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Belgium", 
                "Canada", 
                "Czech Republic", 
                "Denmark", 
                "France", 
                "Hungary", 
                "Korea, Republic of", 
                "Lithuania", 
                "Netherlands", 
                "Serbia", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease", 
        "other_outcome": [
            {
                "description": "Death, MI, stroke and any repeat revascularization (MACCE) rate at 2 years, 3 years and 5 years", 
                "measure": "MACCE", 
                "safety_issue": "No", 
                "time_frame": "2 years, 3 years, 5 years"
            }, 
            {
                "description": "Death will be evaluated at 1 year, 2 years, 3 years and 5 years,  excluding patients lost to follow-up from each arm", 
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "1 year, 2years, 3 years, 5 years"
            }, 
            {
                "description": "MI will be evaluated at 1 year, 2 years, 3 years and 5 years,  excluding patients lost to follow-up from each arm", 
                "measure": "Myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "1 year, 2 years, 3 years and 5 years"
            }, 
            {
                "description": "Stroke will be evaluated at  1 year, 2 years, 3 years and 5 years,  excluding patients lost to follow-up from each arm", 
                "measure": "Stroke", 
                "safety_issue": "No", 
                "time_frame": "1 year, 2 years, 3 years and 5 years"
            }, 
            {
                "description": "Any repeat revascularization will be evaluated at 1 year, 2 years, 3 years and 5 years,  excluding patients lost to follow-up from each arm", 
                "measure": "Repeat revascularization", 
                "safety_issue": "No", 
                "time_frame": "1 year, 2 years, 3 years and 5 years"
            }
        ], 
        "overall_contact": {
            "email": "wfearon@stanford.edu", 
            "last_name": "William F Fearon, MD", 
            "phone": "650-725-2621"
        }, 
        "overall_contact_backup": {
            "email": "frederik.zimmermann@cze.nl", 
            "last_name": "Frederik M Zimmermann, MD", 
            "phone": "0031402398360"
        }, 
        "overall_official": [
            {
                "affiliation": "Stanford University", 
                "last_name": "William F Fearon, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Catharina Hospital Eindhoven, The Netherlands", 
                "last_name": "Nico HJ Pijls, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cardiovascular Center Aalst, Belgium", 
                "last_name": "Bernard De Bruyne, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Death, MI, stroke and any repeat revascularization (MACCE) will be evaluated at 1 year, where subjects contribute data from time of randomization until the occurrence of MACCE or one year follow-up, whichever occurs first.  Subjects who die or are lost to follow up before 1 year will be censored at their last recorded activity.", 
            "measure": "MACCE", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02100722"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Death, MI, and stroke will be evaluated at 3 years, where subjects contribute data from time of enrollment until the occurrence of one of the above events or three year follow-up, whichever occurs first.  Subjects who die or are lost to follow up before this time will be censored at their last recorded activity.", 
            "measure": "Death, MI, and stroke", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Cardiovascular Center Aalst, Belgium", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Catharina Hospital Eindhoven", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Golden Jubilee National Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, Irvine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medtronic", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "St. Jude Medical", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Genae", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}